IRIS
Cao, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.855
AS - Asia 1.289
EU - Europa 489
SA - Sud America 294
AF - Africa 35
OC - Oceania 3
Totale 3.965
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.809
SG - Singapore 690
CN - Cina 403
BR - Brasile 265
FI - Finlandia 149
IE - Irlanda 79
DE - Germania 59
IT - Italia 52
VN - Vietnam 48
SE - Svezia 40
GB - Regno Unito 33
IN - India 33
HK - Hong Kong 32
FR - Francia 24
MX - Messico 18
BD - Bangladesh 17
AR - Argentina 14
CA - Canada 13
RU - Federazione Russa 11
JP - Giappone 10
NG - Nigeria 10
EG - Egitto 8
IQ - Iraq 8
ZA - Sudafrica 8
ES - Italia 7
NL - Olanda 7
PL - Polonia 7
TR - Turchia 7
PK - Pakistan 6
BE - Belgio 4
MA - Marocco 4
TH - Thailandia 4
CO - Colombia 3
CU - Cuba 3
EC - Ecuador 3
ID - Indonesia 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
NP - Nepal 3
PT - Portogallo 3
PY - Paraguay 3
UA - Ucraina 3
UZ - Uzbekistan 3
AF - Afghanistan, Repubblica islamica di 2
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
CR - Costa Rica 2
EE - Estonia 2
KE - Kenya 2
PE - Perù 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GD - Grenada 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.965
Salva come PNG Salva come JPEG
Città #
Dallas 561
Singapore 211
The Dalles 206
Shanghai 176
Helsinki 148
Beijing 138
Ashburn 118
Boardman 102
Chandler 90
Dublin 78
New York 65
Wilmington 48
Los Angeles 35
Milan 32
Hong Kong 31
San Mateo 24
São Paulo 22
Ho Chi Minh City 21
Pune 19
Santa Clara 19
Ann Arbor 16
Seattle 14
Brooklyn 11
Stockholm 11
Benin City 10
Hanoi 10
Lawrence 10
Munich 10
Princeton 10
Leawood 9
Chicago 8
Council Bluffs 8
Lauterbourg 8
Mexico City 8
Phoenix 8
Curitiba 7
Paris 7
Porto Alegre 7
Rio de Janeiro 7
San Francisco 7
Tokyo 7
Warsaw 7
Assago 6
Fairfield 6
Naples 6
Abbiategrasso 5
Belo Horizonte 5
Denver 5
Dhaka 5
Düsseldorf 5
London 5
Montreal 5
Reston 5
Santo André 5
Amsterdam 4
Brasília 4
Brussels 4
Campinas 4
Manchester 4
New Delhi 4
Shijiazhuang 4
Woodbridge 4
Al Fayyum 3
Ankara 3
Atlanta 3
Betim 3
Boston 3
Caxias do Sul 3
Columbus 3
Goiânia 3
Havana 3
Johannesburg 3
Kingston 3
Moscow 3
Mumbai 3
Phuket 3
Querétaro City 3
Tashkent 3
Toronto 3
Alexandria 2
Amman 2
Aracaju 2
Asunción 2
Baku 2
Belém 2
Biên Hòa 2
Bridgetown 2
Buffalo 2
Bắc Giang 2
Changsha 2
Charlotte 2
Chennai 2
Chongqing 2
Conselheiro Lafaiete 2
Erbil 2
Erechim 2
Falkenstein 2
Giza 2
Goianésia 2
Guaratinguetá 2
Totale 2.532
Salva come PNG Salva come JPEG
Nome #
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program 520
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 101
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 91
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach 82
The synergy stent in high-bleeding risk patients: why design matters 70
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 64
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 64
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 60
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 59
Short Versus Long Duration of DAPT After DES Implantation: A Meta-Analysis. 52
Device profile of the Resolute Onyx Zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy 47
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents 47
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 46
Contrast-induced acute kidney injury 44
Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies 44
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 44
Depression and ischemic heart disease 43
Revascularization in patients with valvular heart disease 43
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 42
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent 42
Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention 42
Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention 41
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 41
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 41
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 41
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index 41
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 40
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR 40
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 39
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 39
Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better 39
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial 39
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 38
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI 37
Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome 37
Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI 37
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 36
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike 36
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD 36
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 35
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 35
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 35
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients 35
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation 34
Clopidogrel Monotherapy After 1-Month DAPT in Diabetic Patients Undergoing PCI: Is Less Always More? 34
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 33
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 33
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 33
Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management 32
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 32
The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry 32
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 30
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 30
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry 29
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis 29
Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG 29
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7 29
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 29
Types of myocardial injury and mid-term outcomes in patients with COVID-19 28
From surgical clamping to endovascular flow arrest/reversal: the concept behind the system 28
Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris 28
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 28
Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review 27
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI 27
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 27
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial 27
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI 27
Ticagrelor Monotherapy After Coronary Stenting: Is the GLASS Half Full or Half Empty? 27
Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention 27
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes 26
Stick to the guidelines or clinical judgment: A toss up? 26
Minding the Microcirculation: Is it Worth the Effort? 25
Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review 25
Ticagrelor in Patients With Cancer: 2 Birds With 1 Stone 25
Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria 25
Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess? 25
Ticagrelor With or Without Aspirin in High-Risk Patients With Anemia Undergoing Percutaneous Coronary Intervention: a subgroup analysis of the TWILIGHT trial 25
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study 25
Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week 25
Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention 24
New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention 24
First and recurrent events in the ISCHEMIA trial: two sides of the same coin 24
Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI 24
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis 24
Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry 23
Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon 23
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD 23
Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery 22
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease 22
Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost 22
Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and design 22
Sodium Bicarbonate, Contrast-Associated Acute Kidney Injury, and Long-Term Outcomes: The End of an Era? 22
Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes 22
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 22
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention 20
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes 20
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease 20
Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis 19
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction 19
Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry 18
Totale 3.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.913
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 24 17 7 26 13 0 10
2021/202257 3 2 0 13 2 1 0 6 5 2 15 8
2022/2023487 21 5 13 43 33 30 77 27 92 99 38 9
2023/2024686 69 51 152 37 12 84 51 14 23 37 81 75
2024/20251.095 22 3 17 11 19 139 70 83 198 282 137 114
2025/20261.639 407 294 539 241 127 31 0 0 0 0 0 0
Totale 4.065